Estrogen ameliorates trauma-hemorrhage-induced lung injury via endothelial nitric oxide synthase-dependent activation of protein kinase G

Annals of Surgery

Volumn 248, Issue 2, 2008, Pages 294-302

  Kan, Wen Hong ^a   Hsu, Jun Te ^a,b   Schwacha, Martin G ^a   Choudhry, Mashkoor A ^a   Bland, Kirby I ^a   Chaudry, Irshad H ^a,c  

^a Kentucky   (United States)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1H (1,2,4) OXADIAZOLO (3,4 ALPHA)QUINOXALIN 1 ONE; CELL ADHESION MOLECULE; CHEMOKINE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; FULVESTRANT; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN; ACTIN BINDING PROTEIN; ANTIESTROGEN; AUTACOID; PHOSPHOPROTEIN; VASODILATOR-STIMULATED PHOSPHOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; EDEMA; FLUID RESUSCITATION; HEMORRHAGIC SHOCK; INFLAMMATION; LAPAROTOMY; LUNG INJURY; MALE; MEAN ARTERIAL PRESSURE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SOFT TISSUE INJURY; SPRAGUE DAWLEY RAT; ANALYSIS OF VARIANCE; ANIMAL; DISEASE MODEL; DRUG EFFECT; INJURY; LUNG; LUNG DISEASE; METABOLISM; PROBABILITY; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CHEMOKINES; CYCLIC GMP-DEPENDENT PROTEIN KINASES; CYTOKINES; DISEASE MODELS, ANIMAL; ESTROGEN ANTAGONISTS; INFLAMMATION MEDIATORS; LUNG; LUNG DISEASES; MALE; MICROFILAMENT PROTEINS; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHOPROTEINS; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; SHOCK, HEMORRHAGIC; SIGNAL TRANSDUCTION; WOUNDS AND INJURIES;

EID: 49849085948     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318180a3db     Document Type: Article

References (49)

1. Hildebrand F, Hubbard WJ, Choudhry MA, et al. Effects of 17beta- estradiol and flutamide on inflammatory response and distant organ damage following trauma-hemorrhage in metestrus females. J Leukoc Biol. 2006;80:759-765.
2. Hsieh YC, Frink M, Thobe BM, et al. 17Beta-estradiol downregulates Kupffer cell TLR4-dependent p38 MAPK pathway and normalizes inflammatory cytokine production following trauma-hemorrhage. Mol Immunol. 2007;44:2165-2172.
3. Hsu JT, Hsieh YC, Kan WH, et al. Role of p38 mitogen-activated protein kinase pathway in estrogen-mediated cardioprotection following trauma-hemorrhage. Am J Physiol Heart Circ Physiol. 2007; 292:H2982-H2987.
4. Hsu JT, Kan WH, Hsieh CH, et al. Mechanism of estrogen-mediated attenuation of hepatic injury following trauma-hemorrhage: Akt-depen- dent HO-1 up-regulation. J Leukoc Biol. 2007;82:1019-1026.
5. Meldrum DR. G-protein-coupled receptor 30 mediates estrogen's non- genomic effects after hemorrhagic shock and trauma. Am J Pathol. 2007;170:1148-1151.
6. Yu HP, Hsieh YC, Suzuki T, et al. The PI3K/Akt pathway mediates the nongenomic cardioprotective effects of estrogen following trauma-hemorrhage. Ann Surg. 2007;245:971-977.
7. Lee SY, Andoh T, Murphy DL, et al. 17beta-estradiol activates ICI 182,780-sensitive estrogen receptors and cyclic GMP-dependent thi- oredoxin expression for neuroprotection. FASEB J. 2003;17:947-948.
8. Oelze M, Mollnau H, Hoffmann N, et al. Vasodilator-stimulated phos- phoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ Res. 2000;87:999-1005.
9. Fiedler B, Feil R, Hofmann F, et al. cGMP-dependent protein kinase type I inhibits TAB1-p38 mitogen-activated protein kinase apo- ptosis signaling in cardiac myocytes. J Biol Chem. 2006;281:32831-32840.
10. Takuma K, Phuagphong P, Lee E, et al. Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J Biol Chem. 2001;276:48093-48099.
11. Ha KS, Kim KM, Kwon YG, et al. Nitric oxide prevents 6-hydroxydo- pamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation. FASEB J. 2003;17:1036-1047.
12. Lincoln TM, Pryzwansky KB, Cornwell TL, et al. Cyclic-GMP-dependent protein kinase in smooth muscle and neutrophils. Adv Second Messenger Phosphoprotein Res. 1993;28:121-132.
13. Chen Z, Yuhanna IS, Galcheva-Gargova Z, et al. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. JClin Invest. 1999;103:401-406.
14. Ibarra-Alvarado C, Galle J, Melichar VO, et al. Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling. Mol Pharmacol. 2002;61:312-319.
15. Krause M, Bear JE, Loureiro JJ, et al. The Ena/VASP enigma. J Cell Sci. 2002;115:4721-4726.
16. Krause M, Dent EW, Bear JE, et al. Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol. 2003;19:541-564.
17. Furman C, Sieminski AL, Kwiatkowski AV, et al. Ena/VASP is required for endothelial barrier function in vivo. J Cell Biol. 2007; 179:761-775.
18. Kwiatkowski AV, Gertler FB, Loureiro JJ. Function and regulation of Ena/VASP proteins. Trends Cell Biol. 2003;13:386 -392.
19. Chen L, Daum G, Chitaley K, et al. Vasodilator-stimulated phospho- protein regulates proliferation and growth inhibition by nitric oxide in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2004;24:1403-1408.
20. Draijer R, Vaandrager AB, Nolte C, et al. Expression of cGMP- dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circ Res. 1995;77:897-905.
21. Wentworth JK, Pula G, Poole AW. Vasodilator-stimulated phosphopro- tein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets. Biochem J. 2006;393:555-564.
22. Smolenski A, Bachmann C, Reinhard K, et al. Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem. 1998;273:20029-20035.
23. Moore EE, Moore FA, Harken AH, et al. The two-event construct of postinjury multiple organ failure. Shock. 2005;24(suppl 1):71-74.
24. Knoferl MW, Angele MK, Diodato MD, et al. Female sex hormones regulate macrophage function after trauma-hemorrhage and prevent increased death rate from subsequent sepsis. Ann Surg. 2002;235: 105-112.
25. Hoyt DB, Coimbra R. Trauma systems. Surg Clin North Am. 2007;87:21-35.
26. Kayyali US, Pennella CM, Trujillo C, et al. Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J Biol Chem. 2002;277:42596-42602.
27. Bouvry D, Planes C, Malbert-Colas L, et al. Hypoxia-induced cytoskel- eton disruption in alveolar epithelial cells. Am J Respir Cell Mol Biol. 2006;35:519-527.
28. Comerford KM, Lawrence DW, Synnestvedt K, et al. Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial functional permeability. FASEB J. 2002;16:583-585.
29. Bachmann C, Fischer L, Walter U, et al. The EVH2 domain of the vasodilator-stimulated phosphoprotein mediates tetramerization, F- actin binding, and actin bundle formation. J Biol Chem. 1999;274: 23549-23557.
30. Rosenberger P, Khoury J, Kong T, et al. Identification of vasodilator- stimulated phosphoprotein (VASP) as an HIF-regulated tissue permeability factor during hypoxia. FASEB J. 2007;21:2613-2621.
31. Hsieh YC, Yu HP, Suzuki T, et al. Upregulation of mitochondrial respiratory complex IV by estrogen receptor-beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage. J Mol Cell Cardiol. 2006; 41:511-521.
32. Choudhry MA, Schwacha MG, Hubbard WJ, et al. Gender differences in acute response to trauma-hemorrhage. Shock. 2005;24(suppl 1): 101-106.
33. Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev. 2002;23:665-686.
34. Gao Y, Dhanakoti S, Trevino EM, et al. Role of cGMP-dependent protein kinase in development of tolerance to nitric oxide in pulmonary veins of newborn lambs. Am J Physiol Lung Cell Mol Physiol. 2004; 286:L786-L792.
35. Gao Y, Portugal AD, Negash S, et al. Role of Rho kinases in PKG-mediated relaxation of pulmonary arteries of fetal lambs exposed to chronic high altitude hypoxia. Am J Physiol Lung Cell Mol Physiol. 2007;292:L678 -L684.
36. Hofmann F. The biology of cyclic GMP-dependent protein kinases. JBiol Chem. 2005;280:1-4.
37. Pfeifer A, Klatt P, Massberg S, et al. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J. 1998;17:3045-3051.
38. Halbrugge M, Friedrich C, Eigenthaler M, et al. Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. J Biol Chem. 1990;265:3088 -3093.
39. Reinhard M, Giehl K, Abel K, et al. The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins. EMBO J. 1995; 14:1583-1589.
40. Monks D, Lange V, Silber RE, et al. Expression of cGMP-dependent protein kinase I and its substrate VASP in neointimal cells of the injured rat carotid artery. Eur JClin Invest. 1998;28:416 -423.
41. Dunn TA, Wang CT, Colicos MA, et al. Imaging of cAMP levels and protein kinase A activity reveals that retinal waves drive oscillations in second-messenger cascades. JNeurosci. 2006;26:12807-12815.
42. Sechi AS, Wehland J. ENA/VASP proteins: multifunctional regulators of actin cytoskeleton dynamics. Front Biosci. 2004;9:1294-1310.
43. Galler AB, Garcia Arguinzonis MI, Baumgartner W, et al. VASP-dependent regulation ofactin cytoskeleton rigidity, cell adhesion, and detachment. Histochem Cell Biol. 2006;125:457-474.
44. Bacallao R, Garfinkel A, Monke S, et al. ATP depletion: a novel method to study junctional properties in epithelial tissues. I. Rearrangement of the actin cytoskeleton. J Cell Sci. 1944;107(pt 12):3301-3313.
45. Kwon O, Phillips CL, Molitoris BA. Ischemia induces alterations in actin filaments in renal vascular smooth muscle cells. Am J Physiol Renal Physiol. 2002;282:F1012-F1019.
46. Lahm T, Crisostomo PR, Markel TA, et al. The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury. Shock. 2007;28:4-14.
47. Park JH, Okayama N, Gute D, et al. Hypoxia/aglycemia increases endothelial permeability: role of second messengers and cytoskeleton. Am J Physiol. 1999;277:C1066-C1074.
48. Gill RM, Braz JC, Jin N, et al. Restoration of impaired endothelium- dependent coronary vasodilation in failing heart: role of eNOS phosphorylation and CGMP/cGK-I signaling. Am J Physiol Heart Circ Physiol. 2007;292:H2782-H2790.
49. Kirsch M, Kemp-Harper B, Weissmann N, et al. Sildenafil in hypoxic pulmonary hypertension potentiates a compensatory up-regulation of NO-cGMP signaling. FASEB J. 2008;22:30-40.